International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.1100 (0.00%)
May 2, 2025, 4:00 PM EDT

International Stem Cell Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
9.097.798.187.187.13
Upgrade
Revenue Growth (YoY)
16.64%-4.78%13.99%0.67%-24.75%
Upgrade
Cost of Revenue
3.763.183.272.942.78
Upgrade
Gross Profit
5.324.614.914.244.35
Upgrade
Selling, General & Admin
5.175.25.055.96.79
Upgrade
Research & Development
0.220.070.040.010.31
Upgrade
Operating Expenses
5.395.275.095.917.1
Upgrade
Operating Income
-0.07-0.66-0.18-1.67-2.75
Upgrade
Interest Expense
-0.15-0.14-0.14-0.13-0.11
Upgrade
Other Non Operating Income (Expenses)
00.01-0.010.010.21
Upgrade
EBT Excluding Unusual Items
-0.21-0.79-0.33-1.79-2.66
Upgrade
Asset Writedown
----0.25-0.07
Upgrade
Other Unusual Items
-0.66-1.14-
Upgrade
Pretax Income
-0.21-0.13-0.33-0.9-2.72
Upgrade
Net Income
-0.21-0.13-0.33-0.9-2.72
Upgrade
Net Income to Common
-0.21-0.13-0.33-0.9-2.72
Upgrade
Shares Outstanding (Basic)
88888
Upgrade
Shares Outstanding (Diluted)
88888
Upgrade
Shares Change (YoY)
--2.19%3.90%0.35%
Upgrade
EPS (Basic)
-0.03-0.02-0.04-0.11-0.36
Upgrade
EPS (Diluted)
-0.03-0.02-0.04-0.11-0.36
Upgrade
Free Cash Flow
-0.150.850.33-1.32-0.37
Upgrade
Free Cash Flow Per Share
-0.020.110.04-0.17-0.05
Upgrade
Gross Margin
58.57%59.16%60.04%59.10%60.98%
Upgrade
Operating Margin
-0.75%-8.51%-2.24%-23.29%-38.62%
Upgrade
Profit Margin
-2.30%-1.68%-4.05%-12.53%-38.21%
Upgrade
Free Cash Flow Margin
-1.68%10.90%4.05%-18.39%-5.18%
Upgrade
EBITDA
0.14-0.470.04-1.41-2.5
Upgrade
EBITDA Margin
1.52%-6.02%0.43%-19.63%-35.07%
Upgrade
D&A For EBITDA
0.210.190.220.260.25
Upgrade
EBIT
-0.07-0.66-0.18-1.67-2.75
Upgrade
EBIT Margin
-0.75%-8.51%-2.24%-23.29%-38.62%
Upgrade
Advertising Expenses
0.180.20.220.17-
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.